All In Biotech

Free tool

FAERS Monitor: Foscavir

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020068 or its brand name (Foscavir, Foscarnet Sodium). Reports on generic versions are filed under their own applications.

Reports

1,935

Serious

1,894

98% of reports

Hospitalization

785

Death reported

702

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use502
  • drug ineffective209
  • acute kidney injury197
  • pancytopenia190
  • cytomegalovirus infection182
  • drug resistance145
  • renal impairment124
  • pyrexia111
  • nephropathy toxic109
  • cystitis haemorrhagic100
  • encephalitis cytomegalovirus99
  • cytomegalovirus infection reactivation97
  • renal failure92
  • cytomegalovirus viraemia91
  • myelosuppression91

Reports by year received

View as table
YearReports
200419
200522
200625
200721
200853
200945
201035
201179
201267
201371
201460
201547
2016110
2017158
2018149
2019183
2020159
2021112
202298
202389
2024134
2025138
202661

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,224 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
encephalitis cytomegalovirusSignal993177.32551.3240,851
cystitis haemorrhagicSignal100276.5227.926,506
cytomegalovirus infection reactivationSignal97244.0200.522,728
cytomegalovirus viraemiaSignal91227.0185.319,838
cytomegalovirus infectionSignal182120.3104.721,202
nephropathy toxicSignal109106.688.711,190
drug resistanceSignal14561.752.78,560
pancytopeniaSignal19037.132.46,629
myelosuppressionSignal9127.522.52,298
renal impairmentSignal12416.113.51,741
acute kidney injurySignal19714.012.32,381
renal failureSignal927.56.2518
off label useSignal5026.25.82,295
pyrexiaSignal1113.52.9198
drug ineffective2091.71.567

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.